Stryker Corp (SYK)
369.83
+0.81
(+0.22%)
USD |
NYSE |
Nov 07, 16:00
369.99
+0.16
(+0.04%)
Pre-Market: 20:00
Stryker Revenue (TTM): 21.97B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.97B |
| June 30, 2024 | 21.39B |
| March 31, 2024 | 20.96B |
| December 31, 2023 | 20.50B |
| September 30, 2023 | 19.88B |
| June 30, 2023 | 19.46B |
| March 31, 2023 | 18.95B |
| December 31, 2022 | 18.45B |
| September 30, 2022 | 17.95B |
| June 30, 2022 | 17.63B |
| March 31, 2022 | 17.43B |
| December 31, 2021 | 17.11B |
| September 30, 2021 | 16.67B |
| June 30, 2021 | 16.25B |
| March 31, 2021 | 14.72B |
| December 31, 2020 | 14.35B |
| September 30, 2020 | 14.22B |
| June 30, 2020 | 14.07B |
| March 31, 2020 | 14.96B |
| December 31, 2019 | 14.88B |
| September 30, 2019 | 14.55B |
| June 30, 2019 | 14.20B |
| March 31, 2019 | 13.88B |
| December 31, 2018 | 13.60B |
| September 30, 2018 | 13.28B |
| Date | Value |
|---|---|
| June 30, 2018 | 13.04B |
| March 31, 2018 | 12.73B |
| December 31, 2017 | 12.44B |
| September 30, 2017 | 12.13B |
| June 30, 2017 | 11.96B |
| March 31, 2017 | 11.78B |
| December 31, 2016 | 11.32B |
| September 30, 2016 | 10.88B |
| June 30, 2016 | 10.47B |
| March 31, 2016 | 10.06B |
| December 31, 2015 | 9.946B |
| September 30, 2015 | 9.849B |
| June 30, 2015 | 9.818B |
| March 31, 2015 | 9.749B |
| December 31, 2014 | 9.675B |
| September 30, 2014 | 9.525B |
| June 30, 2014 | 9.287B |
| March 31, 2014 | 9.136B |
| December 31, 2013 | 9.021B |
| September 30, 2013 | 8.891B |
| June 30, 2013 | 8.792B |
| March 31, 2013 | 8.686B |
| December 31, 2012 | 8.657B |
| September 30, 2012 | 8.534B |
| June 30, 2012 | 8.513B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.07B
Minimum
Jun 2020
21.97B
Maximum
Sep 2024
17.59B
Average
17.53B
Median
Revenue (TTM) Benchmarks
| Globus Medical Inc | 2.479B |
| Boston Scientific Corp | 15.91B |
| Alphatec Holdings Inc | 572.74M |
| Orthofix Medical Inc | 771.65M |
| Treace Medical Concepts Inc | 202.86M |